Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-May-24 5:30 PM View:  | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 16-May-24 | Sale | 151,303 | $1.92 | $290,502.00 | (31%) 482.33K to 331.03K | |
| 04-Apr-24 6:11 PM View: | Johnson Anne Nagengast Chief Financial Officer | Atai Life Sciences N.V. (ATAI) | 02-Apr-24 | Sale | 27,410 | $1.85 | $50,708.50 | (27%) 101.0K to 73.59K | |
| 04-Apr-24 6:11 PM View: | Kirpekar Sahil Chief Business Officer | Atai Life Sciences N.V. (ATAI) | 02-Apr-24 | Sale | 35,801 | $1.85 | $66,231.90 | (36%) 100.0K to 64.2K | |
| 04-Apr-24 6:11 PM View: | Rao Srinivas See Remarks | Atai Life Sciences N.V. (ATAI) | 02-Apr-24 | Sale | 61,640 | $1.85 | $114,034.00 | (35%) 178.5K to 116.86K | |
| 15-Mar-24 8:16 PM View: | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 14-Mar-24 | Option Exercise | 350,000 | -- | -- | 264% 132.33K to 482.33K | |
| 15-Mar-24 8:16 PM View: | Kirpekar Sahil Chief Business Officer | Atai Life Sciences N.V. (ATAI) | 14-Mar-24 | Option Exercise | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 15-Mar-24 8:16 PM View: | Rao Srinivas See Remarks | Atai Life Sciences N.V. (ATAI) | 14-Mar-24 | Option Exercise | 175,000 | -- | -- | 5000% 3.5K to 178.5K | |
| 15-Mar-24 8:16 PM View: | Johnson Anne Nagengast Chief Financial Officer | Atai Life Sciences N.V. (ATAI) | 14-Mar-24 | Option Exercise | 100,000 | -- | -- | 10000% 1.0K to 101.0K | |
| 20-Nov-23 9:17 AM View: | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 16-Nov-23 | Private Purchase | 20,000 | $1.16 | $23,120.00 | 18% 112.33K to 132.33K | |
| 14-Sep-23 4:30 PM View: | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 13-Sep-23 | Private Purchase | 40,000 | $1.45 | $57,968.00 | 55% 72.33K to 112.33K | |
| 29-Mar-23 4:05 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 29-Mar-23 | Private Purchase | 1,214,300 | $1.32 | $1,600,440.00 | 4% 32.67M to 33.89M | |
| 30-Mar-23 5:55 PM View: | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 29-Mar-23 | Private Purchase | 70,000 | $1.48 | $103,558.00 | 3000% 2.33K to 72.33K | |
| 02-May-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 29-Apr-22 | Purchase | 21,900 | $4.47 | $97,801.00 | 1% 1.78M to 1.8M | |
| 02-May-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 28-Apr-22 | Private Purchase | 34,700 | $4.46 | $154,689.00 | 2% 1.74M to 1.78M | |
| 28-Apr-22 10:00 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 27-Apr-22 | Purchase | 19,803 | $4.64 | $91,939.40 | 1% 1.72M to 1.74M | |
| 28-Apr-22 10:00 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 26-Apr-22 | Private Purchase | 46,207 | $4.69 | $216,628.00 | 3% 1.68M to 1.72M | |
| 26-Apr-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 25-Apr-22 | Purchase | 8,961 | $4.78 | $42,842.50 | < 1% 1.67M to 1.68M | |
| 26-Apr-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 22-Apr-22 | Private Purchase | 52,820 | $4.83 | $254,962.00 | 3% 1.61M to 1.67M | |
| 03-May-22 4:16 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 21-Apr-22 | Purchase | 68,688 | $4.95 | $340,040.00 | 4% 1.55M to 1.61M | |
| 03-May-22 4:16 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 20-Apr-22 | Private Purchase | 67,703 | $5.09 | $344,514.00 | 5% 1.48M to 1.55M | |
| 20-Apr-22 4:30 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 19-Apr-22 | Purchase | 65,315 | $5.12 | $334,739.00 | 5% 1.41M to 1.48M | |
| 20-Apr-22 4:30 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 18-Apr-22 | Private Purchase | 54,322 | $5.11 | $277,656.00 | 4% 1.36M to 1.41M | |
| 18-Apr-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 14-Apr-22 | Private Purchase | 4,967 | $5.19 | $25,778.70 | < 1% 1.35M to 1.36M | |
| 14-Apr-22 4:15 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 12-Apr-22 | Private Purchase | 55,197 | $4.88 | $269,560.00 | 4% 1.3M to 1.35M | |
| 12-Apr-22 4:30 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 11-Apr-22 | Purchase | 53,926 | $4.83 | $260,554.00 | 4% 1.24M to 1.3M | |
| 12-Apr-22 4:30 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 08-Apr-22 | Private Purchase | 57,689 | $4.81 | $277,640.00 | 5% 1.19M to 1.24M | |
| 19-Jan-22 4:30 PM View: | Auerbach Michael Director | Atai Life Sciences N.V. (ATAI) | 14-Jan-22 | Disposition (other) | 5,559,810 | -- | -- | (91%) 6.08M to 524.31K | |
| 24-Jun-21 4:15 PM View: | Brand Florian See Remarks | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 2,333 | $15.00 | $34,995.00 | 100% 0 to 2.33K | |
| 24-Jun-21 4:16 PM View: | Smiley Andrea Heslin Director | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 4,666 | $15.00 | $69,990.00 | 100% 0 to 4.67K | |
| 24-Jun-21 4:15 PM View: | de Rosnay Alexis Director | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 4,666 | $15.00 | $69,990.00 | 100% 0 to 4.67K | |
| 24-Jun-21 4:15 PM View: | Weaver Gregory L Chief Financial Officer | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 4,666 | $15.00 | $69,990.00 | 100% 0 to 4.67K | |
| 24-Jun-21 4:15 PM View: | Angermayer Christian Director 10% Owner | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase Duplicate | 700,000 | $15.00 | $10,500,000.00 | 3% 20.67M to 21.37M | |
| 24-Jun-21 4:15 PM View: | Auerbach Michael Director | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase Duplicate | 4,666 | $15.00 | $69,990.00 | < 1% 5.56M to 5.56M | |
| 24-Jun-21 4:16 PM View: | Rao Srinivas See Remarks | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 3,500 | $15.00 | $52,500.00 | 100% 0 to 3.5K | |
| 24-Jun-21 4:16 PM View: | Kalali Amir H Director | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 4,666 | $15.00 | $69,990.00 | 100% 0 to 4.67K | |
| 24-Jun-21 4:16 PM View: | Apeiron Investment Group Ltd. 10% Owner | Atai Life Sciences N.V. (ATAI) | 22-Jun-21 | Private Purchase | 700,000 | $15.00 | $10,500,000.00 | 3% 20.67M to 21.37M |
